Agenta Biotechnologies (United States)

Statistics

Publications

Citations

857

Authors

Location

Birmingham, United States

Agenta Biotechnologies (United States) is a company institution in Birmingham, United States known for oral porphyromonas, periodontal disease, and tissue engineering.

ROR

Top concepts

Tissue EngineeringBiochemistryLife SciencesProteoglycansCell SignalingMolecular BiologyExtracellular MatrixHeparan Sulfate ProteoglycansEngineeringBiomaterials

Publications

Intracellular survival and vascular cell-to-cell transmission of Porphyromonas gingivalis

Ling Li, Raynald Michel, Joshua Cohen et al. · BMC Microbiology · 2008 · 111 citations · Full text

Dentistry, Oral Biology, Periodontology +16

Perlecan and vascular endothelial growth factor-encoding DNA-loaded chitosan scaffolds promote angiogenesis and wound healing

Megan S. Lord, April L. Ellis, Brooke L. Farrugia et al. · Journal of Controlled Release · 2017 · 77 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +12

Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer

Stephen Kalscheuer, Vidhi Khanna, Hyunjoon Kim et al. · Scientific Reports · 2019 · 50 citations · Full text

Medicine, Cancer Biology, Oncology +14

Perlecan domain 1 recombinant proteoglycan augments BMP-2 activity and osteogenesis

Arthur A. DeCarlo, Maria E. Belousova, April L. Ellis et al. · BMC Biotechnology · 2012 · 35 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Feasibility of an HA2 Domain-Based Periodontitis Vaccine

Arthur A. DeCarlo, Yi‐Fang Huang, Charles A. Collyer et al. · Infection and Immunity · 2002 · 31 citations · Full text

Dentistry, Immunology, Periodontology +16

1–5 of 10

Authors

AL
April L. Ellis
Agenta Biotechnologies (United States), United States
8 publications · 217 citations
7
h-index

1–1 of 1